Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ritter Pharmaceuticals Inc. (RTTR)

0.2865   -0.006 (-2.12%) 10-21 16:00
Open: 0.294 Pre. Close: 0.2927
High: 0.3 Low: 0.2802
Volume: 181,536 Market Cap: 3M
Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.301 - 0.302 0.302 - 0.304
Low: 0.276 - 0.278 0.278 - 0.28
Close: 0.287 - 0.29 0.29 - 0.293

Technical analysis

as of: 2019-10-21 4:38:21 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 0.42     One year: 0.52
Support: Support1: 0.23    Support2: 0.19
Resistance: Resistance1: 0.36    Resistance2: 0.44
Pivot: 0.30
Moving Average: MA(5): 0.30     MA(20): 0.29
MA(100): 0.80     MA(250): 0.82
MACD: MACD(12,26): -0.08     Signal(9): -0.11
Stochastic oscillator: %K(14,3): 28.50     %D(3): 32.33
RSI: RSI(14): 37.58
52-week: High: 1.85  Low: 0.23  Change(%): -83.9
Average Vol(K): 3-Month: 98554  10-Days: 205038

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
RTTR has closed above bottom band by 40.8%. Bollinger Bands are 64.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to RTTR's normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Ritter Pharma to explore strategic alternatives; shares ahead 20%
Nano cap Ritter Pharmaceuticals ([[RTTR]] +20.3%) is up on almost a 4x surge in volume on the heels of its announcement it has engaged A.G.P./Alliance Glob

Ritter Pharmaceuticals Engages Financial Advisor to Explore Strategic Alternatives
LOS ANGELES, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, announced that it has engaged A.G.P./Alliance Global Partners

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 9.43
Shares Float (M) 7.97
% Held by Insiders 8.56
% Held by Institutions 15.32
Shares Short (K) 366
Shares Short P. Month (K)

Stock Financials

EPS -3.014
Book Value (p.s.) -0.280
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -108.6
Return on Equity (ttm) -220.4
Qtrly Rev. Growth
Gross Profit (p.s.) -0.022
Sales Per Share
EBITDA (p.s.) -2.012
Qtrly Earnings Growth
Operating Cash Flow (M) -17.39
Levered Free Cash Flow (M) -10.38

Stock Valuations

P/E -0.10
P/E Growth Ratio -0.02
P/BV -1.02
P/CF -0.16

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-03-23
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.